
|Articles|November 1, 2012
- Applied Clinical Trials-11-01-2012
- Volume 21
- Issue 11
Act Insert cover
S
Advertisement
Act Insert cover
Articles in this issue
almost 14 years ago
Taking the Pulse of Ethics Committee Viewsalmost 14 years ago
Act Coveralmost 14 years ago
Survey Results of Start-Up Cycle Timesalmost 14 years ago
Business and News Update November 2012almost 14 years ago
Pediatric Drug Developmentalmost 14 years ago
ePRO Industry Growthalmost 14 years ago
Generic Drugs Making Wavesalmost 14 years ago
In the Race to Capture Clinical Data, Does Data Quality Suffer?almost 14 years ago
Are CRCs Reaching Their Tipping Point?almost 14 years ago
EMA's Mid-Year Report Merits ScrutinyAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced
2
Survey Finds US Biotechs Prefer Domestic First-in-Human Trials but FDA Hurdles Are Pushing Them Abroad
3
Breaking the Efficacy Ceiling in IBD and Beyond
4
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
5




